Angiotensin II receptor blockers in the prevention of atrial fibrillation

Author： Barra Silvia   Silvestri Nunzia   Vitagliano Giancarlo   Madrid Alfredo   Gaeta Giovanni  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.10, Iss.9, 2009-06, pp. : 1395-1411

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Up-regulation of CXC Chemokine Receptor 4 Expression in Chronic Atrial Fibrillation Patients with Mitral Valve Disease May Be Attenuated by Renin–Angiotensin System Blockers

By Wang XX   Zhang FR   Zhu JH   Xie XD   Chen JZ  

The Journal of International Medical Research, Vol. 37, Iss. 4, 2009-07 ,pp. : 1145-1151

Field House Publishing

Access to resources Recommend Favorite

Vascular and metabolic effects of angiotensin II receptor blockers

By Barra Silvia   Vitagliano Alice   Cuomo Vittoria   Vitagliano Giancarlo   Gaeta Giovanni  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 2, 2009-02 ,pp. : 173-189

Informa Healthcare

Access to resources Recommend Favorite

Angiotensin II receptor blockers for the treatment of hypertension

By See Sharon  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 11, 2001-11 ,pp. : 1795-1804

Informa Healthcare

Access to resources Recommend Favorite

Use of -Blockers in Atrial Fibrillation

By Kühlkamp V.   Bosch R.   Mewis C.   Seipel L.  

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 1, 2002-01 ,pp. : 37-42

Adis International

Access to resources Recommend Favorite

Role of angiotensin II receptor blockers in atherosclerotic plaque stability

By Cipollone Francesco   Fazia Maria Luigia   Mezzetti Andrea  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 3, 2006-02 ,pp. : 277-285

Informa Healthcare

Access to resources Recommend Favorite